11-56542797-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005245.1(OR5M11):āc.461A>Gā(p.Asp154Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,613,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D154H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001005245.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5M11 | NM_001005245.1 | c.461A>G | p.Asp154Gly | missense_variant | 1/1 | ENST00000528616.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5M11 | ENST00000528616.5 | c.461A>G | p.Asp154Gly | missense_variant | 1/1 | NM_001005245.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000482 AC: 12AN: 248932Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135046
GnomAD4 exome AF: 0.000110 AC: 161AN: 1461566Hom.: 0 Cov.: 35 AF XY: 0.000105 AC XY: 76AN XY: 727054
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.461A>G (p.D154G) alteration is located in exon 1 (coding exon 1) of the OR5M11 gene. This alteration results from a A to G substitution at nucleotide position 461, causing the aspartic acid (D) at amino acid position 154 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at